IsoRay Medical Overview

  • Founded
  • 2004
Founded
  • Status
  • Public
  • Employees
  • 60
Employees
  • Stock Symbol
  • ISR
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $1.23
  • (As of Tuesday Closing)

IsoRay Medical General Information

Description

Isoray Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products that provide more cost-effective cancer treatment. It is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to the cancerous tumor. It derives most of its revenue from the United States of America.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
ASE
Primary Office
  • 350 Hills Street
  • Suite 106
  • Richland, WA 99354
  • United States
+1 (509) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IsoRay Medical Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.23 $1.49 $0.35 - $2.81 $174M 141M 14.8M -$0.05

IsoRay Medical Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 38,268 36,237 21,217 20,280
Revenue 9,902 9,680 7,314 5,923
EBITDA (3,146) (3,291) (5,066) (6,599)
Net Income (3,314) (3,446) (5,144) (6,700)
Total Assets 15,513 8,699 9,422 7,455
Total Debt 897 1,005 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IsoRay Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IsoRay Medical‘s full profile, request access.

Request a free trial

IsoRay Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Isoray Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products
Drug Discovery
Richland, WA
60 As of 2021
000.00
000000000 000.00

00000 00

or in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint o
0000 000000000
Janesville, WI
00 As of 0000
00.000
0000000 0000 00.000

0000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000000000000
Pennington, NJ
00 As of 0000
000.00
00.00 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IsoRay Medical Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SHINE Medical Technologies Private Equity-Backed Janesville, WI 00 00.000 0000000 0000 00.000
0000000 0000000 Corporate Backed or Acquired Pennington, NJ 00 000.00 000000&0 000.00
000000000 0000000 Venture Capital-Backed Hayward, CA 000 00000 00000000000 00000
0-0000 Venture Capital-Backed Shilat, Israel 00 0000 0000000000 0 0000
0000000 Venture Capital-Backed San Luis Obispo, CA 00 000.00 000000000 - 000.00
You’re viewing 5 of 10 competitors. Get the full list »

IsoRay Medical Executive Team (11)

Name Title Board Seat Contact Info
Lori Woods Chief Executive Officer & Board Member
Jonathan Hunt Chief Financial Officer, Finance
Jennifer Streeter Chief Operating Officer, Operations & Vice President
Krista Cline Executive
William Cavanagh III Executive
You’re viewing 5 of 11 executive team members. Get the full list »

IsoRay Medical Board Members (4)

Name Representing Role Since
Lori Woods IsoRay Medical Chief Executive Officer & Board Member 000 0000
Michael Mccormick Self Chairman & Board Member 000 0000
To view IsoRay Medical’s complete board members history, request access »

IsoRay Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IsoRay Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IsoRay Medical‘s full profile, request access.

Request a free trial

IsoRay Medical Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 23-Jan-2008 000000000 00000000 Drug Delivery 00000 000000
Century Park Pictures 28-Jul-2005 Merger/Acquisition Holding Companies 00000 000000
To view IsoRay Medical’s complete investments and acquisitions history, request access »